US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors
Wenwen Yue, Tingting Jiang, Zisheng Ai, Erya Deng, Huihui Chai, Xiao‐Long Li, Hongfeng He, Zhengxian Zhang, Ning Weng, Xiachuan Qin, Jing Fan, Xiaoqing Tang, Wei Heng, Yong Li, Liping Sun, Chengzhong Peng, Huixiong Xu
Abstract
US-guided radiofrequency ablation seems to be an efficacious and safe nonsurgical alternative for patients with secondary hyperparathyroidism receiving long-term dialysis treatment.
Topics & Concepts
MedicineSecondary hyperparathyroidismRadiofrequency ablationClinical endpointHyperparathyroidismRetrospective cohort studyPercutaneousParathyroid hormoneDialysisUrologyInternal medicineSurgeryAblationCalciumRandomized controlled trialParathyroid Disorders and TreatmentsMagnesium in Health and DiseaseThyroid and Parathyroid Surgery